ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

ClinicalTrials.gov ID: NCT00980018

Public ClinicalTrials.gov record NCT00980018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory Trial to Assess the Improvement of Chronic Low-grade Non-hematologic Adverse Events Experienced by Patients With Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Treated With Imatinib When Switched to Nilotinib Treatment

Study identification

NCT ID
NCT00980018
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
52 participants

Conditions and interventions

Interventions

  • Nilotinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2009
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Jun 30, 2021

2009 – 2012

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Highlands Oncology Group Fayetteville Arkansas 72703
Hematology Oncology Services of Arkansas SC Little Rock Arkansas 72205
USC Norris Cancer Center LAC & USC Medical Center Los Angeles California 90033
Southwest Cancer Care Murrieta Poway California 92064
Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village Colorado
Florida Cancer Institute New Port Richey Florida 34655
Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 Ocoee Florida *see dep*
Stroger Cook County Hospital John H. Stroger Hospital Chicago Illinois 60612
St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn Beech Grove Indiana 46107
St. Agnes Hospital Baltimore Maryland 21229
St. Louis University Cancer Center St Louis Missouri 63110
Northwest Cancer Specialists Salmon Creek Office Portland Oregon 97210
Oregon Health Sciences University Portland Oregon 97239
The Jones Clinic Germantown Tennessee 38138
Texas Oncology, P.A. Bedford Texas 76022
Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp Dallas Texas 75231
Texas Oncology Texas Oncology - Sugar Land Dallas Texas 75246
MD Anderson Cancer Center/University of Texas Houston Texas 77031
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00980018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2021 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00980018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →